2,178
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway

, , , , , , , , & show all
Pages 696-709 | Received 08 Dec 2022, Accepted 04 Apr 2023, Published online: 24 Apr 2023

References

  • Benedicto A, Romayor I, Arteta B. 2017. Role of liver ICAM-1 in metastasis. Oncol Lett. 14(4):3883–3892.
  • Burgeiro A, Bento AC, Gajate C, Oliveira PJ, Mollinedo F. 2013. Rapid human melanoma cell death induced by sanguinarine through oxidative stress. Eur J Pharmacol. 705(1-3):109–118.
  • Che G, Huang B, Xie Z, Zhao J, Yan Y, Wu J, Sun H, Ma H. 2019. Trends in incidence and survival in patients with melanoma, 1974-2013. Am J Cancer Res. 9:1396–1414.
  • Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC, Huang XH. 2016. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma. Cancer Lett. 375(1):73–83.
  • De Stefano I, Raspaglio G, Zannoni GF, Travaglia D, Prisco MG, Mosca M, Ferlini C, Scambia G, Gallo D. 2009. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. Biochem Pharmacol. 78(11):1374–1381.
  • Fan T, Chen J, Zhang L, Gao P, Hui Y, Xu P, Zhang X, Liu H. 2016. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway. Mol Cancer. 15:23.
  • Fell JW. 1857. A Treatise on Cancer: and Its Treatment. Stirling, America: Franklin Classics Trade.
  • Fidler IJ. 2003. The pathogenesis of cancer metastasis: the 'seed and soil’ hypothesis revisited. Nat Rev Cancer. 3(6):453–458.
  • Flamini MI, Uzair ID, Pennacchio GE, Neira FJ, Mondaca JM, Cuello-Carrión FD, Jahn GA, Simoncini T, Sanchez AM. 2017. Thyroid hormone controls breast cancer cell movement via integrin αV/β3/SRC/FAK/PI3- kinases. Horm Cancer. 8(1):16–27.
  • Gho YS, Kim PN, Li HC, Elkin M, Kleinman HK. 2001. Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Cancer Res. 61(10):4253–4257.
  • He C, Chen ZY, Li Y, Yang ZQ, Zeng F, Cui Y, He Y, Chen JB, Chen HQ. 2019. miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma. BMC Nephrol. 20(1):127.
  • He J, Yin P, Xu K. 2020. Effect and molecular mechanisms of traditional Chinese medicine on tumor targeting tumor-associated macrophages. Drug Des Devel Ther. 14:907–919.
  • Hu NX, Chen M, Liu YS, Shi Q, Yang B, Zhang HC, Cheng P, Tang Q, Liu ZY, Zeng JG. 2019. Pharmacokinetics of sanguinarine, chelerythrine, and their metabolites in broiler chickens following oral and intravenous administration. J Vet Pharmacol Ther. 42(2):197–206.
  • Kong DH, Kim YK, Kim MR, Jang JH, Lee S. 2018. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. IJMS. 19(4):1057.
  • Kurishima K, Kagohashi K, Ohara G, Miyazaki K, Kawaguchi M, Takayashiki N, Satoh H. 2014. Skin metastasis from small cell lung cancer. Tuberk Toraks. 62(2):147–150.
  • Laines-Hidalgo JI, Muñoz-Sánchez JA, Loza-Müller L, Vázquez-Flota F. 2022. An update of the sanguinarine and benzophenanthridine alkaloids’ biosynthesis and their applications. Molecules. 27(4):1378.
  • Leiter U, Eigentler T, Garbe C. 2014. Epidemiology of skin cancer. In: Reichrath J, editor. Sunlight, Vitamin D and Skin Cancer. New York, NY: Springer New York; p. 120–140.
  • Leong SP, Mihm MC, Jr., Murphy GF, Hoon DS, Kashani-Sabet M, Agarwala SS, Zager JS, Hauschild A, Sondak VK, Guild V, et al. 2012. Progression of cutaneous melanoma: implications for treatment. Clin Exp Metastasis. 29(7):775–796.
  • Li W, Mao Y, Hua B, Gu X, Lu C, Xu B, Pan W. 2022. Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways. Pharm Biol. 60(1):1865–1875.
  • Lin L, Liu YC, Huang JL, Liu XB, Qing ZX, Zeng JG, Liu ZY. 2018. Medicinal plants of the genus Macleaya (Macleaya cordata, Macleaya microcarpa): a review of their phytochemistry, pharmacology, and toxicology. Phytother Res. 32(1):19–48. [InsertedFromOnine]
  • Lo JA, Fisher DE. 2014. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. Science. 346(6212):945–949.
  • Lu CT, Leong PY, Hou TY, Huang SJ, Hsiao YP, Ko JL. 2018. Ganoderma immunomodulatory protein and chidamide down-regulate integrin-related signaling pathway result in migration inhibition and apoptosis induction. Phytomedicine. 51:39–47.
  • Neoh CA, Wu WT, Dai GF, Su JH, Liu CI, Su TR, Wu YJ. 2017. Flaccidoxide-13-acetate extracted from the soft coral Cladiella kashmani reduces human bladder cancer cell migration and invasion through reducing activation of the FAK/PI3K/AKT/mTOR signaling pathway. Molecules. 23(1):58.
  • Nishibaba R, Higashi Y, Su J, Furukawa T, Kawai K, Kanekura T. 2012. CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase. J Dermatol. 39(1):63–67.
  • Pereira L, Horta S, Mateus R, Videira MA. 2015. Implications of Akt2/Twist crosstalk on breast cancer metastatic outcome. Drug Discov Today. 20(9):1152–1158.
  • Pi G, Ren P, Yu J, Shi R, Yuan Z, Wang C. 2008. Separation of sanguinarine and chelerythrine in Macleaya cordata (Willd) R. Br. based on methyl acrylate-co-divinylbenzene macroporous adsorbents. J Chromatogr A. 1192(1):17–24.
  • Prabhu KS, Bhat AA, Siveen KS, Kuttikrishnan S, Raza SS, Raheed T, Jochebeth A, Khan AQ, Chawdhery MZ, Haris M, et al. 2021. Sanguinarine mediated apoptosis in non-small cell lung cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway. Biomed Pharmacother. 144:112358.
  • Pridham KJ, Le L, Guo S, Varghese RT, Algino S, Liang Y, Fajardin R, Rodgers CM, Simonds GR, Kelly DF, et al. 2018. PIK3CB/p110β is a selective survival factor for glioblastoma. Neuro Oncol. 20(4):494–505.
  • Rahman A, Pallichankandy S, Thayyullathil F, Galadari S. 2019. Critical role of H(2)O(2) in mediating sanguinarine-induced apoptosis in prostate cancer cells via facilitating ceramide generation, ERK1/2 phosphorylation, and Par-4 cleavage. Free Radic Biol Med. 134:527–544.
  • Sein TT, Thant AA, Hiraiwa Y, Amin AR, Sohara Y, Liu Y, Matsuda S, Yamamoto T, Hamaguchi M. 2000. A role for FAK in the concanavalin A-dependent secretion of matrix metalloproteinase-2 and -9. Oncogene. 19(48):5539–5542.
  • Serafim TL, Matos JA, Sardão VA, Pereira GC, Branco AF, Pereira SL, Parke D, Perkins EL, Moreno AJ, Holy J, et al. 2008. Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells–nuclear vs. mitochondrial effects. Biochem Pharmacol. 76(11):1459–1475.
  • Siegel RL, Miller KD, Fuchs HE, Jemal A. 2021. Cancer statistics, 2021. CA Cancer J Clin. 71(1):7–33.
  • Slunská Z, Gelnarová E, Hammerová J, Táborská E, Slaninová I. 2010. Effect of quaternary benzo[c]phenanthridine alkaloids sanguilutine and chelilutine on normal and cancer cells. Toxicol in Vitro. 24(3):697–706.
  • Struglics A, Hansson M. 2012. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover. Biochem J. 446(2):213–223.
  • Su Q, Fan M, Wang J, Ullah A, Ghauri MA, Dai B, Zhan Y, Zhang D, Zhang Y. 2019. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma. Cell Death Dis. 10(12):939.
  • Vrublova E, Vostalova J, Vecera R, Klejdus B, Stejskal D, Kosina P, Zdarilova A, Svobodova A, Lichnovsky V, Anzenbacher P, et al. 2008. The toxicity and pharmacokinetics of dihydrosanguinarine in rat: a pilot study. Food Chem Toxicol. 46(7):2546–2553.
  • Wang T, Zhang Y, Bai J, Xue Y, Peng Q. 2021. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma. BMC Cancer. 21(1):1068.
  • Wang Y, Zhang Q, Chen Y, Liang CL, Liu H, Qiu F, Dai Z. 2020. Antitumor effects of immunity-enhancing traditional Chinese medicine. Biomed Pharmacother. 121:109570.
  • Xie YJ, Gao WN, Wu QB, Yao XJ, Jiang ZB, Wang YW, Wang WJ, Li W, Hussain S, Liu L, et al. 2020. Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway. Pharmacol Res. 159:104934.
  • Xu G, Wang Q, Yu B, Pan M. 1997. Coloured illustrations of antitumour Chinese traditional and herbal drugs. Fuzhou, China: Fujian Science and Technology Press.
  • Xue G, Hemmings BA. 2013. PKB/Akt-dependent regulation of cell motility. J Natl Cancer Inst. 105(6):393–404.
  • Yan Z, Lai Z, Lin J. 2017. Anticancer properties of traditional Chinese medicine. Comb Chem High Throughput Screen. 20:423–429.
  • Yasuda M, Tanaka Y, Tamura M, Fujii K, Sugaya M, So T, Takenoyama M, Yasumoto K. 2001. Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinase. Cancer Res. 61(5):2022–2030.
  • Zhang W, Tang B, Huang Q, Hua Z. 2013. Galangin inhibits tumor growth and metastasis of B16F10 melanoma. J Cell Biochem. 114(1):152–161.
  • Zhang HQ, Xie XF, Li GM, Chen JR, Li MT, Xu X, Xiong QY, Chen GR, Yin YP, Peng F, et al. 2021. Erianin inhibits human lung cancer cell growth via PI3K/Akt/mTOR pathway in vitro and in vivo. Phytother Res. 35(8):4511–4525.
  • Zhou J, Yi Q, Tang L. 2019. The roles of nuclear focal adhesion kinase (FAK) on cancer: a focused review. J Exp Clin Cancer Res. 38(1):1–11.
  • Zhu Y, Pan Y, Zhang G, Wu Y, Zhong W, Chu C, Qian Y, Zhu G. 2018. Chelerythrine inhibits human hepatocellular carcinoma metastasis in vitro. Biol Pharm Bull. 41(1):36–46.